Fulgent Genetics to Announce Second Quarter 2018 Financial Results on Monday August 6, 2018
July 16, 2018 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2018...
Fulgent Genetics Reports First Quarter 2018 Financial Results
May 07, 2018 16:05 ET
|
Fulgent Genetics, Inc.
First Quarter 2018 Results: Revenue of $4.7 million, up 9% sequentiallyBillable tests delivered grew 10% sequentially to 4,621GAAP loss of $1.9 million, or $0.11 per shareNon-GAAP loss of $1.2...
Fulgent Genetics to Announce First Quarter 2018 Financial Results on Monday May 7, 2018
April 23, 2018 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its first quarter 2018...
Fulgent Genetics Reports Fourth Quarter and Full Year 2017 Financial Results
February 28, 2018 16:05 ET
|
Fulgent Genetics, Inc.
Fourth Quarter of 2017 Results: Revenue of $4.3 millionGAAP loss of $1.8 million, or $0.10 per shareNon-GAAP loss of $1.0 million, or $0.06 per shareAdjusted EBITDA loss of $952,000 Full Year 2017...
Representatives of Fulgent Genetics to Participate in 2018 BTIG Healthcare Conference
February 23, 2018 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming...
Fulgent Genetics to Announce Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018
February 13, 2018 08:00 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full...
Representatives of Fulgent Genetics to Participate in the Piper Jaffray 29th Annual Healthcare Conference
November 14, 2017 08:30 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming...
Fulgent Genetics Reports Third Quarter 2017 Financial Results
November 06, 2017 16:05 ET
|
Fulgent Genetics, Inc.
Revenue of $4.5 MillionGAAP Loss of $1.1 million, or $0.06 per ShareNon-GAAP loss of $442,000, or $0.02 per ShareAdjusted EBITDA loss of $458,000 TEMPLE CITY, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE)...
Representatives of Fulgent Genetics to Participate in the Credit Suisse 26th Annual Healthcare Conference
October 24, 2017 08:30 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming...
Fulgent Genetics to Announce Third Quarter 2017 Financial Results on November 6, 2017
October 23, 2017 08:30 ET
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2017...